Reported about 8 hours ago
Kenvue, a consumer health products company known for brands like Band-Aid and Tylenol, has faced significant challenges, including a drop in sales and controversies surrounding Tylenol's safety. With a new leadership team in place and strategic changes underway, including potential divestitures, analysts believe Kenvue could rebound in the coming year. The company's current dividend yield is over 5%, offering investors an attractive option while it works to return to growth.
Source: YAHOO